BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21703963)

  • 1. Marker panels for the diagnosis of small hepatocellular carcinoma, a never-ending story.
    Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):513-5. PubMed ID: 21703963
    [No Abstract]   [Full Text] [Related]  

  • 2. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis in hepatocellular carcinoma: does age matter?
    Yeh MM
    Am J Clin Pathol; 2005 Oct; 124(4):491-3. PubMed ID: 16146817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clear cell hepatocellular carcinoma: significance of CK 19].
    Leroy X; Moukassa D; Gosselin B
    Ann Pathol; 1998 Dec; 18(6):512-3. PubMed ID: 10051922
    [No Abstract]   [Full Text] [Related]  

  • 5. [PIVKA-II as a serological marker of hepatocellular carcinoma].
    Jeong SH
    Korean J Hepatol; 2006 Sep; 12(3):315-7. PubMed ID: 16998285
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
    Debruyne EN; Delanghe JR
    Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper and hepatocellular carcinoma.
    Nakakoshi T
    Radiology; 2000 Jan; 214(1):304-6. PubMed ID: 10644143
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary hepatic carcinoid tumours: report of two cases.
    Lau PP; Tint KA; Tse GM; Lui PC
    Pathology; 2006 Oct; 38(5):458-61. PubMed ID: 17008291
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation of metastatic follicular thyroid cancer from hepatocellular carcinoma using Hep Par 1.
    Mullin EJ; Metcalfe MS; Maddern GJ
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2047-8. PubMed ID: 17914993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
    Aoyagi Y; Yanagi M; Asakura H
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.